HHS Stock Analysis: Buy, Sell, or Hold?
$2.75
-0.03 (-1.08%)
▼
5d:
+0.36%
30d:
+14.11%
90d:
-8.94%
BUY
HIGH Confidence
Analysis Updated: May 7, 2026 12:00 AM ET
Earnings: May 13, 2026
4d
Get Alerted When HHS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: HHS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: HHS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.05
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$2.51
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 2.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HHS is currently trading at $2.75, which is considered fair relative to its 30-day fair value range of $2.48 to $2.86. The stock's valuation (Forward PE: 2.6) is in line with its historical norms (2.7). Remarkably, the market is currently pricing in an annual earnings decline of 1.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, HHS is in a downtrend. The price is currently testing key support at $2.73. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: HHS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.50 (+529.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HHS is in a downtrend. The price is currently testing key support at $2.73. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: HHS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.50 (+529.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.48 -
$2.86
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 529.5% below Wall St target ($17.50)
Trading Range Analysis
30-Day Trading Range
$2.48 -
$2.86
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.73
Resistance Level
$2.99
Current Trend
Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.60
Wall Street Target
$17.50
(+529.5%)
Revenue Growth (YoY)
-15.4%
Earnings Growth (YoY)
-90.3%
Profit Margin
-0.5%
Valuation Discount vs History
-1.3% cheaper
PE vs Historical
2.6 vs 2.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.3%
(market-implied from PE analysis)
1-Year Target
$2.74
(-1%)
2-Year Target
$2.71
(-3%)
3-Year Target
$2.67
(-4%)
3-Yr Target (if PE normalizes)
(PE: 3→3)
$2.78
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 2.6 to 2.7
Stabilization Target:
$2.89
(+3.9%)
PE Expansion Potential:
+3.9%
Share & Embed Analysis
Last updated: May 08, 2026 1:45 PM ET
Data refreshes hourly during market hours. Next update: 2:45 PM
Data refreshes hourly during market hours. Next update: 2:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HHS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Conglomerates Stocks
Top-rated stocks in Conglomerates by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HON
Honeywell International … |
BUY
26 analysts |
$248 | 60 BUY |
|
MMM
3M Company |
BUY
19 analysts |
$175 | 61 BUY |
|
BBU
Brookfield Business Part… |
STRONG BUY
6 analysts |
$41 | 58 HOLD |
|
VMI
Valmont Industries Inc |
BUY
6 analysts |
$527 | 64 BUY |
|
PAM
Pampa Energia SA ADR |
BUY
8 analysts |
$114 | 55 HOLD |